The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Open accessAbstract
With the recent FDA approval of the first siRNA‐derived therapeutic, RNA interference (RNAi)‐mediated gene therapy is undergoing a transition from research to the clinical space. The primary obstacle to realization of RNAi therapy has been the delivery of oligonucleotide payloads. Therefore, the main aims is to identify and describe key design features needed for nanoscale vehicles to achieve effective delivery of siRNA‐mediated gene silencing agents in vivo. The problem is broken into three elements: 1) protection of siRNA from degradation and clearance; 2) selective homing to target cell types; and 3) cytoplasmic release of the siRNA payload by escaping or bypassing endocytic uptake. The in vitro and in vivo gene silencing efficiency values that have been reported in publications over the past decade are quantitatively summarized by material type (lipid, polymer, metal, mesoporous silica, and porous silicon), and the overall trends in research publication and in clinical translation are discussed to reflect on the direction of the RNAi therapeutics field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, Z. L., Duan, J., Wang, J., Liu, Q., Shang, R., Yang, X., Lu, P., Xia, C., Wang, L. Q., & Dou, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s155537 · Cited by 81
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Silicon quantum wire array fabrication by electrochemical and chemical dissolution of wafers
Canham, L. T. (1990) · Applied Physics Letters · doi:10.1063/1.103561 · Cited by 7,997
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
Hammond, S. M., Bernstein, E., Beach, D., & Hannon, G. J. (2000) · Nature · doi:10.1038/35005107 · Cited by 3,003
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes.
Miller, J., McLachlan, A. D., & Klug, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03825.x · Cited by 2,476
Wilschut, J. (1990) · Cited by 2,407
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
The Human Genome Project: Lessons from Large-Scale Biology
Collins, F. S., Morgan, M., & Patrinos, A. (2003) · Science · doi:10.1126/science.1084564 · Cited by 1,284
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Genome Engineering With Zinc-Finger Nucleases
Carroll, D. (2011) · Genetics · doi:10.1534/genetics.111.131433 · Cited by 1,076
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 968
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Expression in Escherichia coli of chemically synthesized genes for human insulin.
Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyneker, H. L., Yansura, D. G., Crea, R., Hirose, T., Kraszewski, A., Itakura, K., & Riggs, A. D. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.106 · Cited by 869
New Goals for the U.S. Human Genome Project: 1998-2003
Collins, F. S., Patrinos, A., Jordan, E., Chakravarti, A., Gesteland, R., Walters, L., & groups, T. M. O. T. D. A. N. P. (1998) · Science · doi:10.1126/science.282.5389.682 · Cited by 854
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Jackson, D. A., Symons, R. H., & Berg, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.10.2904 · Cited by 778
Cancer active targeting by nanoparticles: a comprehensive review of literature
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756
Influence of cholesterol on liposome stability and on in vitro drug release
Briuglia, M.-L., Rotella, C., McFarlane, A., & Lamprou, D. A. (2015) · Drug Delivery and Translational Research · doi:10.1007/s13346-015-0220-8 · Cited by 740
Benjaminsen, R. V., Mattebjerg, M. A., Henriksen, J. R., Moghimi, S. M., & Andresen, T. L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.185 · Cited by 735
GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics
Springer, A. D., & Dowdy, S. F. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0736 · Cited by 711
Mechanisms of membrane fusion: disparate players and common principles
Martens, S., & McMahon, H. T. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2417 · Cited by 710
Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Kerr, M. C., & Teasdale, R. D. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00878.x · Cited by 693
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Tasciotti, E., Liu, X., Bhavane, R., Plant, K., Leonard, A. D., Price, B. K., Cheng, M. M.-C., Decuzzi, P., Tour, J. M., Robertson, F., et al. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.34 · Cited by 668
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
Hu, Y.-B., Dammer, E. B., Ren, R.-J., & Wang, G. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0041-1 · Cited by 666
Wnt Signaling and an APC-Related Gene Specify Endoderm in Early C. elegans Embryos
Rocheleau, C. E., Downs, W. D., Lin, R., Wittmann, C., Bei, Y., Cha, Y.-H., Ali, M., Priess, J. R., & Mello, C. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80531-0 · Cited by 660
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 592
Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schäffler, M., Takenaka, S., Möller, W., Schmid, G., Simon, U., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.029 · Cited by 583
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 575
Strategies, design, and chemistry in siRNA delivery systems
Dong, Y., Siegwart, D. J., & Anderson, D. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.004 · Cited by 572
Shaping Cancer Nanomedicine: The Effect of Particle Shape on The In Vivo Journey of Nanoparticles
Toy, R., Peiris, P. M., Ghaghada, K. B., & Karathanasis, E. (2014) · Nanomedicine · doi:10.2217/nnm.13.191 · Cited by 570
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559
Clathrin-independent pathways of endocytosis
Mayor, S., Parton, R. G., & Donaldson, J. G. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016758 · Cited by 525
Toxicology of silica nanoparticles: an update
Murugadoss, S., Lison, D., Godderis, L., Van Den Brule, S., Mast, J., Brassinne, F., Sebaihi, N., & Hoet, P. H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1993-y · Cited by 518
Liu, J. K. H. (2014) · Annals of Medicine & Surgery · doi:10.1016/j.amsu.2014.09.001 · Cited by 515
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S., Keep, R., & Andjelkovic, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 513
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Solid Lipid Nanoparticles as Delivery Systems for Bioactive Food Components
Weiss, J., Decker, E. A., McClements, D. J., Kristbergsson, K., Helgason, T., & Awad, T. (2008) · Food Biophysics · doi:10.1007/s11483-008-9065-8 · Cited by 474
Jaenisch, R., & Mintz, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1250 · Cited by 464
Antibody fragments: Hope and hype
Nelson, A. L. (2010) · mAbs · doi:10.4161/mabs.2.1.10786 · Cited by 463
Tumor penetrating peptides for improved drug delivery
Ruoslahti, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 459
Kawabata, K., Takakura, Y., & Hashida, M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016248701505 · Cited by 456
Chiappini, C., De Rosa, E., Martinez, J. O., Liu, X., Steele, J., Stevens, M. M., & Tasciotti, E. (2015) · Nature Materials · doi:10.1038/nmat4249 · Cited by 446
Aptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Current progress of siRNA/shRNA therapeutics in clinical trials
Burnett, J. C., Rossi, J. J., & Tiemann, K. (2011) · Biotechnology Journal · doi:10.1002/biot.201100054 · Cited by 444
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Tatiparti, K., Sau, S., Kashaw, S., & Iyer, A. (2017) · Nanomaterials · doi:10.3390/nano7040077 · Cited by 429
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419
The great escape: how cationic polyplexes overcome the endosomal barrier
Bus, T., Traeger, A., & Schubert, U. S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00967h · Cited by 409
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Self-citationFu, C., Liu, T., Li, L., Liu, H., Chen, D., & Tang, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.043 · Cited by 390
Lipid Rafts, Caveolae, and Their Endocytosis
(2010) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(10)82003-9 · Cited by 372
Monoclonal Antibodies: A Review
Singh, S., Kumar, N. K., Dwiwedi, P., Charan, J., Kaur, R., Sidhu, P., & Chugh, V. K. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884712666170809124728 · Cited by 371
Lee, J., Lee, K., Moon, S. H., Lee, Y., Park, T. G., & Cheon, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805998 · Cited by 365
Advances in Non-Viral DNA Vectors for Gene Therapy
Hardee, C., Arévalo-Soliz, L., Hornstein, B., & Zechiedrich, L. (2017) · Genes · doi:10.3390/genes8020065 · Cited by 356
Intracellular route and transcriptional competence of polyethylenimine–DNA complexes
Bieber, T., Meissner, W., Kostin, S., Niemann, A., & Elsasser, H.-P. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00129-3 · Cited by 354
Translocation and Endocytosis for Cell-penetrating Peptide Internalization
Jiao, C.-Y., Delaroche, D., Burlina, F., Alves, I. D., Chassaing, G., & Sagan, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056309 · Cited by 345
Advancement and applications of peptide phage display technology in biomedical science
Wu, C.-H., Liu, I.-J., Lu, R.-M., & Wu, H.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 339
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
Porous Nanoparticle Supported Lipid Bilayers (Protocells) as Delivery Vehicles
Liu, J., Stace-Naughton, A., Jiang, X., & Brinker, C. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808018y · Cited by 327
Poly(ethylenimine)-mediated transfection: A new paradigm for gene delivery
Godbey, W. T., Barry, M. A., Saggau, P., Wu, K. K., & Mikos, A. G. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3<321::aid-jbm5>3.0.co;2-r · Cited by 325
Advances in Mammalian cell line development technologies for recombinant protein production
Lai, T., Yang, Y., & Ng, S. (2013) · Pharmaceuticals · doi:10.3390/ph6050579 · Cited by 322
Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
Tanaka, T., Mangala, L. S., Vivas-Mejia, P. E., Nieves-Alicea, R., Mann, A. P., Mora, E., Han, H.-D., Shahzad, M. M. K., Liu, X., Bhavane, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3931 · Cited by 316
Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule
Kaddah, S., Khreich, N., Kaddah, F., Charcosset, C., & Greige-Gerges, H. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.01.017 · Cited by 308
Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA
Parente, R. A., Nir, S., & Szoka, F. C. (1990) · Biochemistry · doi:10.1021/bi00489a031 · Cited by 301
Nano-based delivery of RNAi in cancer therapy
Xin, Y., Huang, M., Guo, W. W., Huang, Q., Zhang, L. Z., & Jiang, G. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0683-y · Cited by 295
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Huang, Y. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2016.12.003 · Cited by 291
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Cell-penetrating peptides: A comparative membrane toxicity study
Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, Ü. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.07.033 · Cited by 290
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
Janas, M. M., Schlegel, M. K., Harbison, C. E., Yilmaz, V. O., Jiang, Y., Parmar, R., Zlatev, I., Castoreno, A., Xu, H., Shulga-Morskaya, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02989-4 · Cited by 279
Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases
Schoch, K. M., & Miller, T. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.010 · Cited by 274
A brief history of gene therapy
Friedmann, T. (1992) · Nature Genetics · doi:10.1038/ng1092-93 · Cited by 273
Polymeric nanoparticles for siRNA delivery and gene silencing
Patil, Y., & Panyam, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.039 · Cited by 270
Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., & Harashima, H. (2004) · Biochemistry · doi:10.1021/bi035802w · Cited by 269
Li, L., Liu, T., Fu, C., Tan, L., Meng, X., & Liu, H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.004 · Cited by 262
Wojnilowicz, M., Glab, A., Bertucci, A., Caruso, F., & Cavalieri, F. (2019) · ACS Nano · doi:10.1021/acsnano.8b05151 · Cited by 262
Qie, Y., Yuan, H., von Roemeling, C. A., Chen, Y., Liu, X., Shih, K. D., Knight, J. A., Tun, H. W., Wharen, R. E., Jiang, W., et al. (2016) · Scientific Reports · doi:10.1038/srep26269 · Cited by 260
Self-citationDüzgünes, N., Wilschut, J., Fraley, R., & Papahadjopoulos, D. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90148-6 · Cited by 255
A novel magnetic crystal–lipid nanostructure for magnetically guided in vivo gene delivery
Namiki, Y., Namiki, T., Yoshida, H., Ishii, Y., Tsubota, A., Koido, S., Nariai, K., Mitsunaga, M., Yanagisawa, S., Kashiwagi, H., et al. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.202 · Cited by 243
Florea, B. I., Meaney, C., Junginger, H. E., & Borchard, G. (2002) · AAPS PharmSci · doi:10.1208/ps040312 · Cited by 243
Ashley, C. E., Carnes, E. C., Epler, K. E., Padilla, D. P., Phillips, G. K., Castillo, R. E., Wilkinson, D. C., Wilkinson, B. S., Burgard, C. A., Kalinich, R. M., et al. (2012) · ACS Nano · doi:10.1021/nn204102q · Cited by 239
Li, X., Chen, Y., Wang, M., Ma, Y., Xia, W., & Gu, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.072 · Cited by 239
Lipidoid-Coated Iron Oxide Nanoparticles for Efficient DNA and siRNA delivery
Jiang, S., Eltoukhy, A. A., Love, K. T., Langer, R., & Anderson, D. G. (2013) · Nano Letters · doi:10.1021/nl304287a · Cited by 236
Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
Conde, J., Ambrosone, A., Sanz, V., Hernandez, Y., Marchesano, V., Tian, F., Child, H., Berry, C. C., Ibarra, M. R., Baptista, P. V., et al. (2012) · ACS Nano · doi:10.1021/nn3030223 · Cited by 232
Jackson, C. L., Chanzy, H. D., Booy, F. P., Drake, B. J., Tomalia, D. A., Bauer, B. J., & Amis, E. J. (1998) · Macromolecules · doi:10.1021/ma9806155 · Cited by 232
Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
Draz, M. S., Fang, B. A., Zhang, P., Hu, Z., Gu, S., Weng, K. C., Gray, J. W., & Chen, F. F. (2014) · Theranostics · doi:10.7150/thno.9404 · Cited by 231
Blumenthal, R., Clague, M. J., Durell, S. R., & Epand, R. M. (2003) · Chemical Reviews · doi:10.1021/cr000036+ · Cited by 226
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., & Ruoslahti, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00273-3 · Cited by 224
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Li, J., Yu, X., Wang, Y., Yuan, Y., Xiao, H., Cheng, D., & Shuai, X. (2014) · Advanced Materials · doi:10.1002/adma.201403877 · Cited by 215
Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes
DIMITRIADIS, G. J. (1978) · Nature · doi:10.1038/274923a0 · Cited by 212
Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy
Xu, X., Wu, J., Liu, Y., Saw, P. E., Tao, W., Yu, M., Zope, H., Si, M., Victorious, A., Rasmussen, J., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b07195 · Cited by 207
GREGORIADIS, G., & NEERUNJUN, D. E. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03681.x · Cited by 206
Oliveira, S., Storm, G., & Schiffelers, R. M. (2006) · BioMed Research International · doi:10.1155/jbb/2006/63675 · Cited by 206
Zheng, C., Zheng, M., Gong, P., Deng, J., Yi, H., Zhang, P., Zhang, Y., Liu, P., Ma, Y., & Cai, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.053 · Cited by 200
Ngamcherdtrakul, W., Morry, J., Gu, S., Castro, D. J., Goodyear, S. M., Sangvanich, T., Reda, M. M., Lee, R., Mihelic, S. A., Beckman, B. L., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404629 · Cited by 195
Kim, B., Pang, H.-B., Kang, J., Park, J.-H., Ruoslahti, E., & Sailor, M. J. (2018) · Nature Communications · doi:10.1038/s41467-018-04390-7 · Cited by 192
Self-citationRecent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
Lee, J.-M., Yoon, T.-J., & Cho, Y.-S. (2013) · BioMed Research International · doi:10.1155/2013/782041 · Cited by 190
Chimeric restriction endonuclease.
Kim, Y. G., & Chandrasegaran, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.883 · Cited by 189
Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins?
Nakanishi, K. (2016) · WIREs RNA · doi:10.1002/wrna.1356 · Cited by 189
The packaging of siRNA within the mesoporous structure of silica nanoparticles
Li, X., Xie, Q. R., Zhang, J., Xia, W., & Gu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.068 · Cited by 187
Polysaccharide-based nucleic acid nanoformulations
Raemdonck, K., Martens, T. F., Braeckmans, K., Demeester, J., & De Smedt, S. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.002 · Cited by 182
Mann, A. P., Scodeller, P., Hussain, S., Joo, J., Kwon, E., Braun, G. B., Mölder, T., She, Z.-G., Kotamraju, V. R., Ranscht, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms11980 · Cited by 180
Self-citationWang, Z., Li, S., Zhang, M., Ma, Y., Liu, Y., Gao, W., Zhang, J., & Gu, Y. (2017) · Advanced Science · doi:10.1002/advs.201600327 · Cited by 179
Lee, J., Kim, J., Jeong, M., Lee, H., Goh, U., Kim, H., Kim, B., & Park, J.-H. (2015) · Nano Letters · doi:10.1021/nl5047494 · Cited by 170
Self-citationPan, H., Liu, L., & Cai, L. (2022) · Biomaterial Engineering · doi:10.1007/978-981-16-5419-0_18 · Cited by 165
Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug
Kumar, M., Yigit, M., Dai, G., Moore, A., & Medarova, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2070 · Cited by 164
Laroui, H., Viennois, E., Xiao, B., Canup, B. S. B., Geem, D., Denning, T. L., & Merlin, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.046 · Cited by 163
Studies in Surface Science and Catalysis
(1998) · Studies in surface science and catalysis · doi:10.1016/s0167-2991(98)80561-2 · Cited by 157
Target-Specific Gene Silencing of Layer-by-Layer Assembled Gold–Cysteamine/siRNA/PEI/HA Nanocomplex
Lee, M., Park, S.-J., Park, K., Kim, K. S., Lee, H., & Hahn, S. K. (2011) · ACS Nano · doi:10.1021/nn2017793 · Cited by 153
Kang, J., Joo, J., Kwon, E. J., Skalak, M., Hussain, S., She, Z., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2016) · Advanced Materials · doi:10.1002/adma.201600634 · Cited by 151
Self-citationCellular uptake and intracellular trafficking of oligonucleotides
Juliano, R. L., & Carver, K. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.005 · Cited by 149
Many commonly used siRNAs risk off-target activity
Snøve, O., & Holen, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.175 · Cited by 149
Functional Delivery of siRNA in Mice Using Dendriworms
Agrawal, A., Min, D., Singh, N., Zhu, H., Birjiniuk, A., von Maltzahn, G., Harris, T. J., Xing, D., Woolfenden, S. D., Sharp, P. A., et al. (2009) · ACS Nano · doi:10.1021/nn900201e · Cited by 147
FDA approves patisiran to treat hereditary transthyretin amyloidosis
Wood, H. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0065-0 · Cited by 145
Alameh, M., Lavertu, M., Tran‐Khanh, N., Chang, C., Lesage, F., Bail, M., Darras, V., Chevrier, A., & Buschmann, M. D. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01297 · Cited by 142
Multi-stage delivery nano-particle systems for therapeutic applications
Serda, R. E., Godin, B., Blanco, E., Chiappini, C., & Mauro Ferrari, B. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.05.004 · Cited by 140
Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 140
Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries
Kwon, E. J., Skalak, M., Bu, R. L., & Bhatia, S. N. (2016) · ACS Nano · doi:10.1021/acsnano.6b03858 · Cited by 137
N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient siRNA Delivery
Liu, G., Xie, J., Zhang, F., Wang, Z., Luo, K., Zhu, L., Quan, Q., Niu, G., Lee, S., Ai, H., et al. (2011) · Small · doi:10.1002/smll.201100825 · Cited by 129
Kim, M. W., Jeong, H. Y., Kang, S. J., Jeong, I. H., Choi, M. J., You, Y. M., Im, C. S., Song, I. H., Lee, T. S., Lee, J. S., et al. (2019) · Theranostics · doi:10.7150/thno.30228 · Cited by 128
Xie, Y., Kim, N. H., Nadithe, V., Schalk, D. L., Thakur, A. B., Kılıç, A., Lum, L. G., Bassett, D. J. P., & Merkel, O. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.029 · Cited by 126
Progress and perspective of inorganic nanoparticle-based siRNA delivery systems
Jiang, Y. Y., Huo, S., Hardie, J. M., Liang, X., & Rotello, V. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1134486 · Cited by 125
Kim, B., Sun, S., Varner, J. A., Howell, S. B., Ruoslahti, E. I., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201902952 · Cited by 124
Self-citationPolymeric nanoparticles for siRNA delivery: Production and applications
Cavallaro, G., Sardo, C., Craparo, E. F., Porsio, B., & Giammona, G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.008 · Cited by 123
Antibody-Mediated Delivery of Anti– KRAS -siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
Bäumer, S., Bäumer, N., Appel, N., Terheyden, L., Fremerey, J., Schelhaas, S., Wardelmann, E., Buchholz, F., Berdel, W. E., & Müller‐Tidow, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2017 · Cited by 122
Uchida, M., Kosuge, H., Terashima, M., Willits, D. A., Liepold, L. O., Young, M., McConnell, M. V., & Douglas, T. (2011) · ACS Nano · doi:10.1021/nn102863y · Cited by 116
Breaking in and busting out: Cell-penetrating peptides and the endosomal escape problem
Lecher, J. C., Nowak, S. J., & McMurry, J. (2017) · Biomolecular Concepts · doi:10.1515/bmc-2017-0023 · Cited by 112
Olson, M. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4338 · Cited by 110
Multifunctional Gold Nanorods for siRNA Gene Silencing and Photothermal Therapy
Shen, J., Kim, H., Mu, C., Gentile, E., Mai, J., Wolfram, J., Ji, L., Mauro Ferrari, B., Mao, Z., & Shen, H. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400103 · Cited by 108
Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery
Shen, H., Rodriguez‐Aguayo, C., Xu, R., González-Villasana, V., Mai, J., Huang, Y., Zhang, G., Guo, X., Bai, L., Qin, G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2764 · Cited by 108
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Kruspe, S., & Giangrande, P. H. (2017) · Biomedicines · doi:10.3390/biomedicines5030045 · Cited by 106
Membrane contact, fusion and hexagonal (HII) transitions in phosphatidylethanolamine liposomes
Allen, T. M., Hong, K., & Papahadjopoulos, D. (1990) · Biochemistry · doi:10.1021/bi00464a013 · Cited by 105
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
Choi, K. Y., Silvestre, O. F., Huang, X., Min, K. H., Howard, G. P., Hida, N., Jin, A. J., Carvajal, N., Lee, S. W., Hong, J.-I., et al. (2014) · ACS Nano · doi:10.1021/nn500085k · Cited by 104
Yi, Y., Kim, H. J., Mi, P., Zheng, M., Takemoto, H., Toh, K., Kim, B. S., Hayashi, K., Naito, M., Matsumoto, Y., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.041 · Cited by 101
Self-citationKleusch, C., Hersch, N., Hoffmann, B., Merkel, R., & Csiszár, Á. (2012) · Molecules · doi:10.3390/molecules17011055 · Cited by 100
Buyens, K., Meyer, M., Wagner, E., Demeester, J., Smedt, S. C. D., & Sanders, N. N. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.026 · Cited by 100
Joo, J., Kwon, E. J., Kang, J., Skalak, M., Anglin, E. J., Mann, A. P., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2016) · Nanoscale Horizons · doi:10.1039/c6nh00082g · Cited by 100
Self-citationOptimized siRNA-PEG Conjugates for Extended Blood Circulation and Reduced Urine Excretion in Mice
Iversen, F., Yang, C., Dagnæs‐Hansen, F., Schaffert, D., Kjems, J., & Gao, S. (2013) · Theranostics · doi:10.7150/thno.5743 · Cited by 99
Probing the inherent stability of siRNA immobilized on nanoparticle constructs
Barnaby, S. N., Lee, A., & Mirkin, C. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409431111 · Cited by 97
Anderson, D. S., Patchin, E. S., Silva, R. M., Uyeminami, D. L., Sharmah, A., Guo, T., Das, G. K., Brown, J. M., Shannahan, J. H., Gordon, T., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv005 · Cited by 97
Mahajan, U. M., Teller, S., Sendler, M., Palankar, R., van den Brandt, C., Schwaiger, T., Kühn, J., Ribback, S., Glöckl, G., Evert, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-311393 · Cited by 97
Cho, Y., Yoon, T., Jang, E., Hong, K. S., Lee, S. Y., Kim, O. R., Park, C.-S., Kim, Y.-J., Yi, G., & Chang, K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.004 · Cited by 96
siRNA Delivery: From Lipids to Cell‐penetrating Peptides and Their Mimics
Gooding, M., Browne, L., Quinteiro, F. M., & Selwood, D. L. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12052 · Cited by 95
Wierzbiński, K. R., Szymański, T., Rozwadowska, N., Rybka, J. D., Zimna, A., Zalewski, T., Nowicka-Bauer, K., Malcher, A., Nowaczyk, M., Krupiński, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22018-0 · Cited by 95
The Business of RNAi Therapeutics in 2012
Haussecker, D. (2012) · Molecular Therapy: Nucleic Acids · doi:10.1038/mtna.2011.9 · Cited by 93
Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery
Qi, R., Liu, S., Chen, J., Xiao, H., Yan, L., Huang, Y., & Jing, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.015 · Cited by 93
Conde, J., Ambrosone, A., Hernández, Y., Tian, F., McCully, M., Berry, C. C., Baptista, P. V., Tortiglione, C., & de la Fuente, J. M. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.008 · Cited by 91
Current status and future perspectives of gold nanoparticle vectors for siRNA delivery
Artiga, Á., Serrano‐Sevilla, I., Matteis, L. D., Mitchell, S. G., & de la Fuente, J. M. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb02484g · Cited by 91
Pinnapireddy, S. R., Duse, L., Strehlow, B., Schäfer, J., & Bakowsky, U. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.06.022 · Cited by 90
Efficient Cytosolic Delivery of siRNA Using HDL‐Mimicking Nanoparticles
Yang, M., Jin, H., Chen, J., Ding, L., Ng, K. K., Lin, Q., Lovell, J. F., Zhang, Z., & Zheng, G. (2011) · Small · doi:10.1002/smll.201001589 · Cited by 89
Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32
Agemy, L., Kotamraju, V. R., Friedmann‐Morvinski, D., Sharma, S., Sugahara, K. N., & Ruoslahti, E. I. (2013) · Molecular Therapy · doi:10.1038/mt.2013.191 · Cited by 88
Zhang, L., Wang, T., Li, L., Wang, C., Su, Z., & Li, J. (2012) · Chemical Communications · doi:10.1039/c2cc33472k · Cited by 87
Tong, W. Y., Alnakhli, M., Bhardwaj, R., Apostolou, S., Sinha, S., Fraser, C. K., Kuchel, T. R., Kuss, B. J., & Voelcker, N. H. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0365-y · Cited by 86
Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy
Bertucci, A., Kim, K., Kang, J., Zuidema, J. M., Lee, S. H., Kwon, E. J., Kim, D., Howell, S. B., Ricci, F., Ruoslahti, E. I., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07980 · Cited by 86
Self-citationRole of Cell Membrane–Vector Interactions in Successful Gene Delivery
Vaidyanathan, S., Orr, B. G., & Holl, M. M. B. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00200 · Cited by 84
Quantitative evaluation of siRNA delivery in vivo
Pei, Y., Hancock, P. J., Zhang, H., Bartz, R., Cherrin, C., Innocent, N., Pomerantz, C. J., Seitzer, J. L., Koser, M. L., Abrams, M. T., et al. (2010) · RNA · doi:10.1261/rna.2255810 · Cited by 82
The Human Genome Project, and recent advances in personalized genomics
Wilson, B. J., & Nicholls, S. G. (2015) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s58728 · Cited by 78
Cited by
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332
DNA hydrogel-based gene editing and drug delivery systems
Mo, F., Jiang, K., Zhao, D., Wang, Y., Song, J., & Tan, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.018 · Cited by 304
Delfi, M., Sartorius, R., Ashrafizadeh, M., Sharifi, E., Zhang, Y., De Berardinis, P., Zarrabi, A., Varma, R. S., Tay, F. R., Smith, B. R., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101119 · Cited by 253
Metadata
- Authors
- Kim, B., Park, J., & Sailor, M. J.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2019-09-30
- Volume
- 31
- Issue
- 49
- Pages
- e1903637-e1903637
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2977584490
- Cited by
- 298
- References
- 255
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.